These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 32977663)
1. c-Jun N-Terminal Kinase as a Therapeutic Target in Experimental Autoimmune Encephalomyelitis. Bagnoud M; Briner M; Remlinger J; Meli I; Schuetz S; Pistor M; Salmen A; Chan A; Hoepner R Cells; 2020 Sep; 9(10):. PubMed ID: 32977663 [TBL] [Abstract][Full Text] [Related]
2. Myelin oligodendrocyte glycoprotein (MOG35-55)-induced experimental autoimmune encephalomyelitis is ameliorated in interleukin-32 alpha transgenic mice. Yun J; Gu SM; Yun HM; Son DJ; Park MH; Lee MS; Hong JT Oncotarget; 2015 Dec; 6(38):40452-63. PubMed ID: 26564962 [TBL] [Abstract][Full Text] [Related]
3. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation. Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550 [TBL] [Abstract][Full Text] [Related]
4. Connexin 30 Deficiency Attenuates Chronic but Not Acute Phases of Experimental Autoimmune Encephalomyelitis Through Induction of Neuroprotective Microglia. Fang M; Yamasaki R; Li G; Masaki K; Yamaguchi H; Fujita A; Isobe N; Kira JI Front Immunol; 2018; 9():2588. PubMed ID: 30464764 [TBL] [Abstract][Full Text] [Related]
5. Systemic exposure to a single dose of ferucarbotran aggravates neuroinflammation in a murine model of experimental autoimmune encephalomyelitis. Hsiao YP; Huang CH; Lin YC; Jan TR Int J Nanomedicine; 2019; 14():1229-1240. PubMed ID: 30863056 [TBL] [Abstract][Full Text] [Related]
6. Transcript analysis of laser capture microdissected white matter astrocytes and higher phenol sulfotransferase 1A1 expression during autoimmune neuroinflammation. Guillot F; Garcia A; Salou M; Brouard S; Laplaud DA; Nicot AB J Neuroinflammation; 2015 Jul; 12():130. PubMed ID: 26141738 [TBL] [Abstract][Full Text] [Related]
7. Induction of experimental autoimmune encephalomyelitis in the absence of c-Jun N-terminal kinase 2. Nicolson K; Freland S; Weir C; Delahunt B; Flavell RA; Bäckström BT Int Immunol; 2002 Aug; 14(8):849-56. PubMed ID: 12147621 [TBL] [Abstract][Full Text] [Related]
8. Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation. Becquet L; Abad C; Leclercq M; Miel C; Jean L; Riou G; Couvineau A; Boyer O; Tan YV J Neuroinflammation; 2019 Mar; 16(1):64. PubMed ID: 30894198 [TBL] [Abstract][Full Text] [Related]
9. Characterization of myelin oligodendrocyte glycoprotein (MOG)35-55-specific CD8+ T cells in experimental autoimmune encephalomyelitis. Peng Y; Zhu FZ; Chen ZX; Zhou JX; Gan L; Yang SS; Gao S; Liu QQ Chin Med J (Engl); 2019 Dec; 132(24):2934-2940. PubMed ID: 31855963 [TBL] [Abstract][Full Text] [Related]
10. Clinical and immunological control of experimental autoimmune encephalomyelitis by tolerogenic dendritic cells loaded with MOG-encoding mRNA. Derdelinckx J; Mansilla MJ; De Laere M; Lee WP; Navarro-Barriuso J; Wens I; Nkansah I; Daans J; De Reu H; Jolanta Keliris A; Van Audekerke J; Vanreusel V; Pieters Z; Van der Linden A; Verhoye M; Molenberghs G; Hens N; Goossens H; Willekens B; Cras P; Ponsaerts P; Berneman ZN; Martínez-Cáceres EM; Cools N J Neuroinflammation; 2019 Aug; 16(1):167. PubMed ID: 31416452 [TBL] [Abstract][Full Text] [Related]
11. HIV-1 Tat protein attenuates the clinical course of experimental autoimmune encephalomyelitis (EAE). Karampoor S; Zahednasab H; Bokharaei-Salim F; Mirzaei R; Mojallal-Tabatabaei Z; Esghaei M; Keyvani H Int Immunopharmacol; 2020 Jan; 78():105943. PubMed ID: 31830622 [TBL] [Abstract][Full Text] [Related]
13. Cytokine production profiles in chronic relapsing-remitting experimental autoimmune encephalomyelitis: IFN-γ and TNF-α are important participants in the first attack but not in the relapse. Hidaka Y; Inaba Y; Matsuda K; Itoh M; Kaneyama T; Nakazawa Y; Koh CS; Ichikawa M J Neurol Sci; 2014 May; 340(1-2):117-22. PubMed ID: 24655735 [TBL] [Abstract][Full Text] [Related]
14. A co-ultramicronized palmitoylethanolamide/luteolin composite mitigates clinical score and disease-relevant molecular markers in a mouse model of experimental autoimmune encephalomyelitis. Contarini G; Franceschini D; Facci L; Barbierato M; Giusti P; Zusso M J Neuroinflammation; 2019 Jun; 16(1):126. PubMed ID: 31221190 [TBL] [Abstract][Full Text] [Related]
15. TRAIL-Mediated Suppression of T Cell Receptor Signaling Inhibits T Cell Activation and Inflammation in Experimental Autoimmune Encephalomyelitis. Chyuan IT; Tsai HF; Wu CS; Sung CC; Hsu PN Front Immunol; 2018; 9():15. PubMed ID: 29403497 [TBL] [Abstract][Full Text] [Related]
17. Rapamycin Ameliorates Experimental Autoimmune Encephalomyelitis by Suppressing the mTOR-STAT3 Pathway. Hou H; Miao J; Cao R; Han M; Sun Y; Liu X; Guo L Neurochem Res; 2017 Oct; 42(10):2831-2840. PubMed ID: 28600752 [TBL] [Abstract][Full Text] [Related]
19. Actin-Binding Protein Cortactin Promotes Pathogenesis of Experimental Autoimmune Encephalomyelitis by Supporting Leukocyte Infiltration into the Central Nervous System. Samus M; Li YT; Sorokin L; Rottner K; Vestweber D J Neurosci; 2020 Feb; 40(7):1389-1404. PubMed ID: 31911458 [TBL] [Abstract][Full Text] [Related]